Medication info
Ezetimibe/Simvastatin Tablet 10/10

Ezetimibe/Simvastatin Tablet 10/10

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
Ilhwa Co., Ltd.
Appearance
A white to pale yellow, bidirectional convex, rectangular tablet
Packaging
30 tablets (10 tablets/PTPX3)
Approval status
Active

MFDS item code 201603895 · Approved 2016.06.24 · Insurance code 640903250

Summary

Main use
Treatment of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients taking this medicine must follow a standard cholesterol-lowering diet before and during treatment. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range of this medicine is 10/10mg to 10/40mg once daily. The usual recommended starting dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10mg once daily. After starting treatment or adjusting the dose, check blood lipid levels and adjust the dose at intervals of 4 weeks or more. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, this medicine is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with Abnormal Liver Function). Administration in patients with renal impairment and chronic kidney disease No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg once daily in the evening. Use higher doses in these patients with caution and monitor them closely (see Precautions for Use, 5. General Precautions). Administration in the elderly No dosage adjustment is necessary in the elderly. Concomitant use with other medicines (See Precautions for Use, 6. Interactions.) Administer this medicine at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day.

Ingredients

Manufacturer
Ilhwa Co., Ltd.

Efficacy & effects

Treatment of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular diseases due to hypercholesterolemia
  • dyslipidemia
View approved original text

This medication helps to lower total cholesterol, LDL-cholesterol, ApoB protein, and triglyceride levels in patients with primary hypercholesterolemia and mixed hyperlipidemia, while increasing HDL-cholesterol levels. It is especially used as an adjunct to other lipid-lowering treatments for patients with homozygous familial hypercholesterolemia or used alone if other treatments are ineffective. This medication should be administered in conjunction with an appropriate diet and is used when dietary control alone is insufficient. Additionally, it is important to confirm and, if necessary, treat secondary causes of dyslipidemia, such as diabetes and hypothyroidism, before using this medication. Regular monitoring of lipid levels is recommended to evaluate the treatment effect, and treatment and evaluation are also advised for patients with acute coronary events. Overall, this medication is used to manage blood lipid levels and reduce cardiovascular risk.

How to take

Adult dose

Patients taking this medicine must follow a standard cholesterol-lowering diet before and during treatment. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range of this medicine is 10/10mg to 10/40mg once daily. The usual recommended starting dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10mg once daily. After starting treatment or adjusting the dose, check blood lipid levels and adjust the dose at intervals of 4 weeks or more. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, this medicine is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 5. General Precautions, Patients with Abnormal Liver Function). Administration in patients with renal impairment and chronic kidney disease No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg once daily in the evening. Use higher doses in these patients with caution and monitor them closely (see Precautions for Use, 5. General Precautions). Administration in the elderly No dosage adjustment is necessary in the elderly. Concomitant use with other medicines (See Precautions for Use, 6. Interactions.) Administer this medicine at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day.

Precautions

This medication can cause serious muscle disorders such as myopathy or rhabdomyolysis, so if muscle pain or weakness symptoms occur, you must notify your doctor immediately. This medication should not be administered to patients with certain liver conditions or abnormally high liver enzyme levels. Pregnant or nursing women should not take this medication, and women who could become pregnant must confirm their pregnancy status before use. This medication may increase the risk of side effects when taken with certain strong drugs, so consult your physician or pharmacist if you are taking other medications. Elderly patients or those with reduced kidney function require extra caution when taking this medication and should have regular blood tests to check liver and muscle health. If any muscle-related adverse symptoms appear, you should discontinue use immediately and consult healthcare professionals, especially since the risk of muscle side effects increases with higher dosages of this medication. While taking this medication, limit alcohol intake, and inform your doctor if there are changes in your health status. Also, this medication may not be suitable for patients with certain genetic metabolic disorders, so if you have a history of drug allergies or adverse reactions, be sure to inform your healthcare provider. This medication is only used in children with restrictions and should be taken in adolescents under medical supervision. Finally, when receiving a new prescription from another doctor while taking this medication, be sure to inform them that you are currently taking this medication.

Side effects

  • Myopathy
  • rhabdomyolysis
  • creatine kinase elevation
  • headache
  • diarrhea
  • influenza
  • upper respiratory tract infection
  • myalgia
  • limb pain
  • fatigue
Show 100 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • paresthesia
  • depression
  • cholelithiasis
  • cholecystitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reaction with systemic symptoms
  • erythema multiforme
  • liver damage
  • weakness
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • immune-mediated necrotizing myopathy
  • specific cranial nerve dysfunction
  • tremor
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disturbances
  • cognitive impairment
  • myasthenia gravis
  • ocular myasthenia
  • interstitial lung disease
  • lupus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • cholestatic jaundice
  • liver fat changes
  • cirrhosis
  • fulminant liver necrosis
  • liver cancer
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle paralysis
  • anemia
  • increased aminotransferase levels
  • elevated ALP
  • elevated ɤ-GT
  • increased bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • increased HbA1c
  • elevated fasting blood glucose levels
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly closed container. It is best to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

A white to pale yellow, bidirectional convex, rectangular tablet

Package unit

30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.